Gene · 84444
Papers2,742
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 2,742
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Shared genetic architecture of schizophrenia and lupus identifies pleiotropic loci with distinct downstream mechanisms. | Hum Mol Genet | 2026 | 42822865 | PubTator, text mining | PubMed |
| Targeting the Epigenetic-Immune Axis in Acute Myeloid Leukemia: Current Advances and Future Directions. | Curr Oncol Rep | 2026 | 42809184 | PubTator, text mining | PubMed |
| Erratum: DOT1L promotes cell proliferation and invasion by epigenetically regulating STAT5B in renal cell carcinoma. | Am J Cancer Res | 2026 | 42724530 | PubTator, text mining | PubMed |
| Correction for Sepulveda et al., Proteolytic activation of c-MYC facilitated by DOT1L. | Proc Natl Acad Sci U S A | 2026 | 42709827 | PubTator, text mining | PubMed |
| Engineered Cyanobacteria-Hydrogel Microecological System for Oxygen Reprogramming Synergizes Immunomodulation With Anabolism in Osteoarthritis Therapy. | Adv Sci (Weinh) | 2026 | 42671032 | PubTator, text mining | PubMed |
| Genome-Wide Identification of a Chromatin-Splicing Regulatory Axis Driven by DOT1L in MLL-Rearranged Acute Myeloid Leukemia. | Genes (Basel) | 2026 | 42650050 | PubTator, text mining | PubMed |
| Targeting DOT1L Epigenetic Moonlighting in MLL-Rearranged Leukemia. | Cells | 2026 | 42587807 | PubTator, text mining | PubMed |
| A Comprehensive Reactive-Oxygen-Species-Scavenging Metal-Organic Framework Orchestrates the AMPK-DOT1L-H3K79me3 Cascade to Alleviate Osteoarthritis. | Biomater Res | 2026 | 42582552 | PubTator, text mining | PubMed |
| Degraders of histone lysine methyltransferases: Progress, challenges, and opportunities. | Drug Discov Today | 2026 | 42542162 | PubTator, text mining | PubMed |
| Targeting senescence-associated secretory phenotype macrophage: apigenin inhibits DOT1L-dependent H3K79me2 at IL1A to fight SASP in senescent macrophages. | Front Mol Biosci | 2026 | 42534541 | PubTator, text mining | PubMed |
| Proteolytic activation of c-MYC facilitated by DOT1L. | Proc Natl Acad Sci U S A | 2026 | 42520114 | PubTator, text mining | PubMed |
| Association of DOT1L histone methyltransferase with non-syndromic orofacial clefts in a cohort of children of African and Asian ancestry. | medRxiv | 2026 | 42428095 | PubTator, text mining | PubMed |
| An update on DOT1LWT/MUT modulators as a promising anticancer strategy. | Bioorg Med Chem | 2026 | 42424823 | PubTator, text mining | PubMed |
| Glioblastoma stem cell growth requires DOT1L-MED23 control of enhancer accessibility. | Cell Rep | 2026 | 42397736 | PubTator, text mining | PubMed |
| Transcriptomic Profiling Identifies Higher DOT1L Expression as a Candidate Biomarker for a Positive Response to Gemcitabine in Cholangiocarcinoma. | Cancer Genomics Proteomics | 2026 | 42373229 | PubTator, text mining | PubMed |
| Roles of histone lysine methylation in neurodevelopment and related disorders. | Ibrain | 2026 | 42371607 | PubTator, text mining | PubMed |
| Epigenetic regulation of cardiac physiology and pathophysiology: biological sex matters. | J Cardiovasc Aging | 2026 | 42369572 | PubTator, text mining | PubMed |
| Co-Phosphoregulatory Network Underlying Functional Coherence of TLK1 and TLK2 Kinase Paralogs. | Int J Mol Sci | 2026 | 42353285 | PubTator, text mining | PubMed |
| The MLLT3 YEATS domain binds histone marks (H3K9/18/27ac/cr) and ncRNA (7SK), linking transcription and RNA signaling to regulate hematopoiesis. | Cell Rep | 2026 | 42268713 | PubTator, text mining | PubMed |
| Next generation technologies for CRISPR-based epigenome and transcriptional modulation. | Curr Opin Biomed Eng | 2026 | 42266835 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/84444/papers